Weather Icon 16.8°C Partly Cloudy
140 jobs at risk as Recipharm investigate closing Ashton site
Wednesday 19th December 2018 @ 12:34 by Lee Wild
Ashton News

Ashton-Under-Lyne based pharmaceutical company Recipharm have announced that its looking at closing its manufacturing plant.

The company say the decision to initiate the process came after a strategic review which shown the facility hadn’t turned a profit for a number of years.

Around 140 people are employed at the plant currently and the company say they’re likely to be affected if a final decision is taken.

The company has made losses averaging approximately 1.5 million annually over the past three years.

Thomas Eldered, CEO of Recipharm, says: “We have taken this decision as there is no likely prospect of the facility in Ashton-under-Lyne being able to deliver an acceptable return in the medium term. It has clearly been a difficult choice as any closure will affect approximately 140 of our employees who have demonstrated commitment and hard work to provide high quality products and services. It is our intention to ensure fair and respectful treatment to all throughout this process and redeploy people where possible within the Group in the event of closure”.

“Such a change will enable us to focus our attention on the most competitive and efficient manufacturing facilities in our Group. At a strategic level, we continue to pursue our mission to develop and manufacture pharmaceuticals for demanding customers for global use. As such, our financial objectives remain unchanged.”

Globally the company employ around 6,000 employees and manufacture various medicines, produce clinical trial materials and develop a range of pharmaceutical products.